Chemical imbalance
A chemical imbalance is the informal explanation that depression comes from the brain being short of a chemical messenger, usually serotonin, and that an antidepressant tops it back up. People may hear it from a prescriber or a friend as the reason a medication is worth trying. It is not a clinical term or a diagnosis, and no test measures it directly. Research has not supported the simple idea of a serotonin shortage. That does not mean antidepressants cannot help. It means how they work is not fully understood, and depression probably has many causes.
Also called: Serotonin imbalance, Low serotonin.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
What is a chemical imbalance?
It is a shorthand for a prescription rather than a finding about you. The phrase says that a chemical messenger in the brain, almost always serotonin, is too low, and that the medication puts it back. It gets said because it is short, and because it makes a medication sound like it has a target.
Nothing in a clinic measures your serotonin, so no test confirms the phrase or rules it out. Two people using it can also mean different things: one means the medication has something to act on, another means something in their brain is broken. Neither of those is written in your chart.
Is depression caused by low serotonin?
The simple version has no evidence behind it. A 2023 umbrella review in Molecular Psychiatry brought together 17 systematic reviews, meta-analyses and large studies covering serotonin metabolites, receptors, the serotonin transporter, tryptophan depletion and genetics, with the literature searched up to December 2020. In the main areas of serotonin research it found no consistent evidence of an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations. The two largest genetic studies it looked at, with 115,257 and 43,165 people, gave no support either.
The argument itself is not finished. The review authors have since answered their critics in the same journal, and what is disputed there is how much of the serotonin story survives.
NIMH describes the cause differently: genetic, biological, environmental and psychological factors all play a role in depression. Researchers have also put a different frame forward, in which depression is inflexibility in the emotional and cognitive circuits of the brain and the treatments that help, serotonin medications among them, work by increasing neuroplasticity. Both pictures are wider than one chemical, and neither says your medication is wrong for you.
Do antidepressants work if there is no chemical imbalance?
In trials they do. A 2018 network meta-analysis in the Lancet pooled 522 trials and 116,477 adults with major depression and found all 21 antidepressants more effective than placebo, with the size of the effect differing between drugs and the certainty of the evidence rated moderate to very low. Whether a medication helps you is a separate question from whether the serotonin story is right, and a treatment can work while the first explanation of how it works turns out to be incomplete.
What the US label claims is narrow. The Lexapro label says the mechanism of antidepressant action of escitalopram is presumed to be linked to potentiation of serotonergic activity in the central nervous system resulting from its inhibition of neuronal reuptake of serotonin. The word presumed is theirs. UK guidance from the NHS is written the same way, that it is thought antidepressants work by affecting the activity of chemical messengers in the brain, with serotonin and noradrenaline linked to mood and emotion.
The reuptake part starts with the first doses, which is why side effects often arrive first. What takes weeks is whatever follows it in the brain. NIMH puts the usual wait at 4 to 8 weeks, and says sleep, appetite, energy and concentration often improve before mood lifts.
Does this change whether you should take an antidepressant?
That is a decision for you and your prescriber, and the serotonin research does not settle it on its own. If you were told your brain was short of serotonin and now read that the evidence for that is thin, the thing to do with it is raise it at your next appointment.
Stopping suddenly brings a problem of its own. NIMH says not to stop a prescribed medication without help from a health care provider, who can adjust the plan and lower the dose slowly. If your mood is dropping, tell your prescriber rather than waiting for the next appointment.
What to do
Ask your prescriber two things: what this medication is expected to do for your symptoms, and how you will both tell in 4 to 8 weeks whether it is doing it. Write down which symptoms you want changed first, since sleep, appetite and energy often move before mood. If you want to come off, ask for a plan to do it slowly rather than stopping on your own. If your mood drops, or you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number.
How long antidepressants take to work, week by week
How withClaro helps
- Log mood, sleep and energy each day, next to your dose
- See the 4 to 8 week picture instead of one bad day
- Share a PDF report with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry, 2023.
- Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Ploderl M, Horowitz MA. The serotonin hypothesis of depression: both long discarded and still supported?. Molecular Psychiatry, 2023.
- Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet, 2018.
- Page CE, Epperson CN, Novick AM, Duffy KA, Thompson SM. Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder. Molecular Psychiatry, 2024.
- National Institute of Mental Health. Depression. NIMH (nimh.nih.gov), 2024.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- National Health Service (NHS). Antidepressants: Overview. NHS, 2026.
- National Institute of Mental Health (NIMH). Mental Health Medications. NIMH, 2024.
All glossary terms